Concepedia

Publication | Open Access

FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy

35

Citations

12

References

2022

Year

Abstract

NCT02996110.

References

YearCitations

Page 1